Table 3.
Laboratory values
| Controls | HIV | P-value | |
|---|---|---|---|
| Fasting plasma glucose (mmol · L−1) | 5.2 ± 0.9 | 6.8 ± 3.2 | <0.01 |
| Total cholesterol (mg · dL−1) | 167 ± 43 | 151 ± 47 | 0.01 |
| LDL-C (mg · dL−1) | 103 ± 34 | 96 ± 39 | 0.17 |
| Non-HDL-C (mg · dL−1) | 118 ± 39 | 117 ± 39 | 0.85 |
| HDL-C (mg · dL−1) | 49 ± 17 | 34 ± 17 | <0.01 |
| Total-C · HDL-C−1 | 4.11 ± 2.95 | 6.71 ± 6.98 | <0.01 |
| Non-HDL-C · HDL-C−1 | 3.06 ± 2.96 | 5.71 ± 6.98 | <0.01 |
| TGs (mg · dL−1) | 67 ± 35 | 155 ± 432 | 0.03 |
| Log(TGs) (mg · dL−1) | 1.78 ± 0.19 | 1.94 ± 0.33 | <0.01 |
| TGs < 150 mg · dL−1 (%) | 94 | 87 | 0.15 |
| Log(TGs) · HDL-C−1 | 0.048 ± 0.044 | 0.114 ± 0.169 | 0.02 |
| Atherogenic dyslipidemia (%) | 3 | 11 | 0.03 |
| CD4+ lymphocytes (× 106 L−1) | ~ | 353 ± 215 | ~ |
| Urinary Na+ (mmol · L−1) | 116 ± 59 | 91 ± 52 | <0.01 |
| Urinary K+ (mmol · L−1) | 74 ± 32 | 67 ± 33 | 0.12 |
Note: Data are mean (SD) or proportions (%).
Abbreviations: HIV, untreated patients with human immunodeficiency virus; C, cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TGs, triglycerides; Na+, sodium; K+, potassium; SD, standard deviation.